Become a client
  • EN
  • KZ
  • RU
Back
Johnson&Johnson
JNJ
Stock price
$ 163.99
Expected price
$185.09
Returns for 6 months
-8.2%
Dividend income
$4.02
More
Number of shares
Commission of the bank:
0%
Brokerage commission:
0.00
Value:
Add to cart
Make an order
Add to cart
Overview
Value dynamics
$

How to assess the success of investments?

Because the investment strategy is drawn up individually, there is no unique instruction for determining profitable or unprofitable positions. It all depends on your goals and risk tolerance.

About Company Johnson&Johnson

The American holding Johnson & Johnson specializes in the manufacture of healthcare and hygiene products. It ranks first in the world's top of companies with the largest output of medical equipment. Founded in 1886 as a family business, the company was initially engaged in the manufacture of bandaging products. The shares were put up for sale in 1944, shortly after, a thriving corporation set after swallowing up its European and North American competitors. The Company aims for the transition to the environmentally-clean manufacturing. To achieve this, a number of factories have switched to solar energy. Moreover, Johnson & Johnson avoid using plastic packaging for liquid products wherever possible. The medical specialization of the holding still stands for oncology, immunology, infectious diseases, neurology, and psychiatry. Johnson & Johnson actively invests in these areas' development. The company's current capitalization hits $317 billion. The Johnson & Johnson corporation is comprised of over 250 companies; it owns rights to over 120 brands. Alex Gorski is the Company's Director General since 2012. At the beginning of the Noughties, he was working for the Company's rivals for a while, but afterward, he returned and was rather speedily promoted. The General Director's power is not absolute; in fact, the extended holding is managed by the Board of the Company. Shares of Johnson & Johnson are rated as stable, growing in value slowly but steadily though.

Why is it worth investing?
JNJ
$163.99
Johnson&Johnson
Commission of the bank:
0%
Brokerage commission:
0.00
Value:
Add to cart
Make an order
Similar stocks
Similar stocks
Go to Catalogue